VidhiSangh

Supreme Court of India · 05/09/2023

PRAKASH BANG versus GLAXO SMITHKLINE PHARMACEUTICALS LTD. & ANR.

[2023] 12 S.C.R. 567 · 2023 INSC 794

AI-generated headnote. Verify against the judgment before relying on it. Paragraph numbers refer to the judgment.

Summary

The Court upheld dismissal of a consumer claim alleging that a hepatitis-B vaccine caused myositis and disability. On the evidence in this case, the complainant failed to establish the asserted condition and its causal connection to vaccination even on a preponderance of probabilities. Unsupported medical affidavits did not become sufficient proof merely because the manufacturer had not cross-examined their authors.

Issues

  1. Whether the complainant proved the alleged condition and its causal link to the vaccine.
  2. Whether untested medical affidavits established liability and omission of the alleged adverse reaction from product information amounted to deficiency on these facts.

Held

Result

Appeal dismissed; NCDRC dismissal of the complaint upheld. No costs; pending applications disposed of.

Judgment PDF: Supreme Court of India, [2023] 12 S.C.R. 567.